Therapeutic Innovation Australia is funded by the Australian Government through the National Collaborative Research Infrastructure Strategy. TIA provides support to a consortium of Australian translational health facilities, and undertakes other initiatives to support therapeutic development, including quality system documents (iQDOCs) and the Australian Therapeutic Pipeline.
Our capabilities span the fields of drug screening, pharmacometrics, biopharmaceuticals, cell-based therapies, integrated preclinical development, clinical trials infrastructure and personalised medicine.
Our newsletters communicate important information to stakeholders and share information on the activities of our consortium.
* indicates required